Search for a command to run...
EVOQ Remedies Ltd. currently stands out as a deep value pick due to its extremely low valuation metrics compared to its peers, despite lacking revenue and profitability. The company's high PE ratio alongside no ROE and other profitability metrics indicates underlying challenges, yet its low market cap presents potential for recovery if operational metrics improve.
Stocks | CMP | Market Cap | P/E | ROCE (%) | Debt/Equity |
---|---|---|---|---|---|
EVOQ Remedies Ltd. | ₹3.38 | ₹8.42Cr | 95.75 | - | - |
ADANIENT | ₹2,283.00 | ₹2,63,499.29Cr | 43.53 | 11.81% | 1.45 |
REDINGTON | ₹243.85 | ₹19,063.56Cr | 13.20 | 23.63% | 0.37 |
CPPLUS | ₹1,246.40 | ₹14,610.54Cr | 107.99 | 41.16% | 0.46 |
CELLO | ₹535.15 | ₹11,820.66Cr | 120.15 | 43.92% | 0.32 |
HONASA | ₹298.95 | ₹9,721.38Cr | 151.70 | 8.99% | - |
MMTC | ₹62.18 | ₹9,327.00Cr | 134.15 | 6.90% | - |